Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma (original) (raw)

• Evans, R. D. et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades: 1965–1984. Chest 91, 65S– 74S (1987).
  Article PubMed Google Scholar
• Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255–281 (1999).
  Article CAS PubMed Google Scholar
• Daniels, S. E. et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 383, 247– 250 (1996).
  Article CAS PubMed Google Scholar
• A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nature Genet. 15, 389– 392 (1997).
• Ober, C. et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum. Mol. Genet. 7, 1393–1398 (1998).
  Article CAS PubMed Google Scholar
• Wjst, M. et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics 58, 1–8 (1999).
  Article CAS PubMed Google Scholar
• Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258–2261 ( 1998).
  Article CAS PubMed Google Scholar
• Gavett, S.H. et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527–1536 ( 1995).
  Article CAS PubMed Google Scholar
• Keane-Myers, A., Wysocka, M., Trinchieri, G. & Wills-Karp, M. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J. Immunol. 161, 919 –926 (1998).
  CAS PubMed Google Scholar
• Ewart, S. E. et al. Identification of quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am. J. Resp. Cell. Molec. Biol.
• Wetsel, R. A., Fleischer, D. T. & Haviland, D. L. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 265, 2435–2440 ( 1990).
  CAS PubMed Google Scholar
• Polorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
  Article Google Scholar
• Vogel, S. N. et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an lpsn gene: In vivo evidence for a dominant negative mutation. J. Immunol. 162, 5666–5670 (1999).
  CAS PubMed Google Scholar
• Johnson, E. & Hetland, G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand. J. Immunol. 27, 489–493 (1988).
  Article CAS PubMed Google Scholar
• Hindmarsh, E. J. & Marks, R. M. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J. Immunol. 160, 6128–6136 ( 1998).
  CAS PubMed Google Scholar
• Wozencraft, A. O., Sayers, G. & Blackwell, J. M. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J. Exp. Med. 164, 1332–1337 ( 1986).
  Article CAS PubMed Google Scholar
• Bergh, K. & Iversen, O. J. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma. J. Immunol. Methods 152, 79–87 (1992).
  Article CAS PubMed Google Scholar
• Heller, T. et al. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163, 985– 994 (1999).
  CAS PubMed Google Scholar
• Hong, K., Kinoshita, T., Miyazaki, W., Izawa, T. & Inoue, K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade . J. Immunol. 122, 2418– 2423 (1979).
  CAS PubMed Google Scholar
• Wittmann, M. et al. C5a suppresses the production of IL-12 by IFN-γ -primed and lipopolysaccharide-challenged human monocytes. J. Immunol. 162, 6763–6769 ( 1999).
  CAS PubMed Google Scholar
• Braun, M. C., Lahey, E. & Kelsall, B. L. Selective suppression of IL-12 production by chemoattractants . J. Immunol. 164, 3009– 3017 (2000).
  Article CAS PubMed Google Scholar
• Gerard, C. & Gerard, N. P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775–808 (1994).
  Article CAS PubMed Google Scholar
• Loots, G. G. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288,136– 140 (2000).
  Article CAS PubMed Google Scholar
• Fearon, D. T. The complement system and adaptive immunity. Semin. Immunol. 10, 355–361 (1998).
  Article CAS PubMed Google Scholar
• Mosser, D. M. & Karp, C. L. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11, 406–411 (1999).
  Article CAS PubMed Google Scholar
• Wang, C. et al. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood 85, 2570– 2578 (1995).
  CAS PubMed Google Scholar
• Wang, C., Gerard, N.P. & Nicholson-Weller, A. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. J. Immunol. 156, 786–792 (1996).
  CAS PubMed Google Scholar
• Kilgore, K. S. et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κ B activation. Am. J. Pathol. 150, 2019–2031 (1997).
  CAS PubMed PubMed Central Google Scholar
• Morgan, E. L. et al. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937–3942 (1992).
  CAS PubMed Google Scholar
• Schindler, R., Gelfand, J. A. & Dinarello, C. A. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76, 1631–1638 (1990).
  CAS PubMed Google Scholar
• Cavaillon, J.M., Fitting, C., Haeffner-Cavaillon, N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages . Eur. J. Immunol. 20, 253– 257 (1990).
  Article CAS PubMed Google Scholar
• Sam, H. & Stevenson, M. M. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria. Clin. Exp. Immunol. 117, 343–349 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y., Rollins, S. A., Madri, J. A. & Matis, L. A. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl Acad. Sci. USA 92, 8955–8959 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Tsuji, R. F. et al. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ: a possible initiating role of B cells. J. Exp. Med. 186, 1015–1026 ( 1997).
  Article CAS PubMed PubMed Central Google Scholar
• Gervais, F., Stevenson, M. & Skamene, E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J. Immunol. 132, 2078–2083 (1984).
  CAS PubMed Google Scholar
• Barton, P. A. & Warren, J. S. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61, 1474–1481 (1993).
  CAS PubMed PubMed Central Google Scholar
• Trinchieri, G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83–243 (1998).
  Article CAS PubMed Google Scholar
• Hopken, U. E., Lu, B., Gerard, N. P. & Gerard, C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186, 749– 756 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• van der Pouw Kraan, T. C. et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J. Immunol. 158, 5560–5565 (1997).
  CAS PubMed Google Scholar
• Naseer, T. et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 155, 845–851 ( 1997).
  Article CAS PubMed Google Scholar
• Germer, S., Holland, M. J. & Higuchi, R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10, 258–266 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Karp, C. L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228– 231 (1996).
  Article CAS PubMed Google Scholar